Sader, Helio S <br/><br/>
Antimicrobial Activity of Dalbavancin against Staphylococcus aureus with Decreased Susceptibility to Glycopeptides, Daptomycin, and/or Linezolid from U.S. Medical Centers.  [electronic resource] 

 -  Antimicrobial agents and chemotherapy  03 2018 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1098-6596 
<br/><br/><label>Standard No.: </label>10.1128/AAC.02397-17  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aminoglycosides--pharmacology<br/>Anti-Bacterial Agents--pharmacology<br/>Daptomycin--pharmacology<br/>Drug Resistance, Multiple, Bacterial--drug effects<br/>Hospitals<br/>Humans<br/>Linezolid--pharmacology<br/>Lipoglycopeptides--pharmacology<br/>Microbial Sensitivity Tests<br/>Staphylococcal Infections--drug therapy<br/>Staphylococcus aureus--drug effects<br/>Teicoplanin--analogs & derivatives<br/>United States--epidemiology<br/>Vancomycin--pharmacology